ABL1 and acute lymphoblastic leukemia: This phenomenon is consistent with the recent “lineage-specific clearance” theory proposed by Kim et al. (25), who demonstrated that 43% of patients harbored non-ALL derived BCR::ABL1-positive cells, a subgroup characterized by delayed BCR::ABL1 clearance.